Your browser doesn't support javascript.
loading
Temsirolimus combined with cyclophosphamide and etoposide for pediatric patients with relapsed/refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium trial (TACL 2014-001).
Tasian, Sarah K; Silverman, Lewis B; Whitlock, James A; Sposto, Richard; Loftus, Joseph P; Schafer, Eric S; Schultz, Kirk R; Hutchinson, Raymond J; Gaynon, Paul S; Orgel, Etan; Bateman, Caroline M; Cooper, Todd M; Laetsch, Theodore W; Sulis, Maria Luisa; Chi, Yueh-Yun; Malvar, Jemily; Wayne, Alan S; Rheingold, Susan R.
Afiliação
  • Tasian SK; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia; Philadelphia, PA, USA; Perelman School of Medicine at the University of Pennsylvania; Philadelphia, PA.
  • Silverman LB; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Division of Pediatric Hematology-Oncology, Boston Children's Hospital; Boston, MA.
  • Whitlock JA; Division of Haematology/Oncology, Hospital for Sick Children and the University of Toronto; Toronto, ON.
  • Sposto R; Department of Preventive Medicine, Keck School of Medicine, University of Southern California; Los Angeles, CA.
  • Loftus JP; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia; Philadelphia, PA.
  • Schafer ES; Dan L. Duncan Institute for Clinical and Translational Research, Baylor College of Medicine and Texas Children's Cancer Center; Houston, TX.
  • Schultz KR; Division of Hematology/Oncology/Bone Marrow Transplant, British Columbia Children's Hospital; Vancouver, BC.
  • Hutchinson RJ; Division of Hematology/Oncology, CS Mott Children's Hospital; Ann Arbor, MI.
  • Gaynon PS; Division of Hematology/Oncology, Children's Hospital Los Angeles, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California; Los Angeles, CA.
  • Orgel E; Division of Hematology/Oncology, Children's Hospital Los Angeles, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California; Los Angeles, CA.
  • Bateman CM; Cancer Centre for Children, The Children's Hospital at Westmead; Westmead, NSW.
  • Cooper TM; Division of Hematology/Oncology, Seattle Children's Hospital Cancer and Blood Disorders Center; Seattle, WA.
  • Laetsch TW; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia; Philadelphia, PA, USA; Perelman School of Medicine at the University of Pennsylvania; Philadelphia, PA.
  • Sulis ML; Department of Pediatrics, Memorial Sloan Kettering Cancer Center; New York, NY.
  • Chi YY; Division of Hematology/Oncology, Children's Hospital Los Angeles, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California; Los Angeles, CA.
  • Malvar J; Division of Hematology/Oncology, Children's Hospital Los Angeles, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California; Los Angeles, CA.
  • Wayne AS; Division of Hematology/Oncology, Children's Hospital Los Angeles, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California; Los Angeles, CA.
  • Rheingold SR; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia; Philadelphia, PA, USA; Perelman School of Medicine at the University of Pennsylvania; Philadelphia, PA. rheingold@chop.edu.
Haematologica ; 107(10): 2295-2303, 2022 10 01.
Article em En | MEDLINE | ID: mdl-35112552
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Leucemia-Linfoma Linfoblástico de Células Precursoras Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Panamá
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Leucemia-Linfoma Linfoblástico de Células Precursoras Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Panamá